Lipid-lowering and antioxidant activities of Jiang-Zhi-Ning in Traditional Chinese Medicine

Journal of Ethnopharmacology

Volumn 134, Issue 3, 2011, Pages 919-930

  Chen, Jianxin ^a   Zhao, Huihui ^a   Yang, Ying ^a   Liu, Bing ^a   Ni, Jian ^a   Wang, Wei ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Cell culture; Cholesterol metabolism; Hypolipidemic effect; Jiang Zhi Ning in Traditional Chinese Medicine

Indexed keywords

ATORVASTATIN; CHINESE DRUG; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; ENDOTHELIN 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; JIANG ZHI NING; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MALONALDEHYDE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CHINESE MEDICINE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DRUG EFFECT; HYPERLIPIDEMIA; LIPID DIET; MALE; NONHUMAN; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; CELLS, CULTURED; DRUGS, CHINESE HERBAL; HUMANS; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; MALE; MEDICINE, CHINESE TRADITIONAL; RATS; RATS, WISTAR;

POLYGONUM CUSPIDATUM; RATTUS; RATTUS NORVEGICUS;

EID: 79954417113     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2011.01.048     Document Type: Article

References (24)

1. R.D. Abbott, P.W. Wilson, W.B. Kannel, and W.P. Castelli High density lipoprotein-cholesterol, total cholesterol screening and myocardial infarction. The Framingham Study Atherosclerosis 8 1988 207 211
2. A.A. Adeneye, O.O. Adeyemi, and E.O. Agbaje Anti-obesity and antihyperlipidemic effect of HUNTERIA UMBELLATA SEED extract in experimental hyperlipidaemia Journal of Ethnopharmacology 2008 10.1016/j.jep.2010.05.009
3. S. Alladi, and K.R. Shanmugasundaram Induction of hypercholesterolaemia by supplementing soy protein with acetate generating amino-acids Nutrition Reports International 40 1989 893 899
4. I. Bjorkhem, Z. Araya, and M. Rudling Differences in the regulation of the classical and the alternative pathway for bile acid synthesis in human liver. No coordinate regulation of CYP7A1 and CYP27A1 Biological Chemistry 277 2002 26804 26807 (Pubitemid 34951685)
5. Z. Chen, R. Peto, and R. Collins Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations BMJ 303 1991 276 282
6. J.R. Downs, M. Clearfield, S. Weis, E. Whitney, D.R. Shapiro, P.A. Beere, A. Langendorfer, E.A. Stein, W. Kruyer, and GottoF A.M. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels JAMA 279 1998 1659 1661
7. J. Galled, K. Heermeier, and C. Wanner Atherogenic lipoproteins, oxidative stress, and cell death Kidney International Supplement 71 1999 S62 65
8. A.L. Gould Cholesterol reduction yields clinical benefit Circulation 91 1995 2274 2282
9. Han, X., 2008. The effect of Jiang-Zhi-Ning and the main monomers on cholesterol metabolism. Doctoral Thesis, Beijing University of Chinese Medicine
10. J. He, D. Gu, K. Reynolds, X. Wu, P. Muntner, J. Zhao, J. Chen, D. Liu, J. Mo, P.K. Whelton, and InterASIA Collaborative Group Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China Circulation 110 2004 405 411 (Pubitemid 38993849)
11. E. Jeffl Protein binding to the low density lipoprotein receptor promoter in vivo is differently affected by gene activation in primary human cells Journal of Lipid Research 36 1995 383 392
12. D.W. Li, L. Zhang, and Z.L. Xia Choice of hyperlipidemia model animals as well as analysis and improvement of common method of establishing models Chinese Journal of Clinical Rehabilitation 10 2006 145 146
13. D.J. Maron, S. Fazio, and M.F. Linton Current perspectives on statins Circulation 101 2000 207
14. J.G. Menke, K.L. Macnaul, and N.S. Hayes A novel liver X receptor agonist establishes species differences in the regulation of cholesterol 7alpha-hydroxylase (CYP7a) Endocrinology 143 2002 2548 2558 (Pubitemid 34701318)
15. W.M. Pandak, C. Schwarz, and P.B. Hylemon Effects of CYP7A1 overexpression on cholesterol and bile acid homeostasis American Journal of Physiology, Gastrointestinal and Liver Physiology 281 2001 878 889
16. C.R. Pulingger, and C.S.G. Eng Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype The Journal of Clinical Investigation l10 2002 l09 l17
17. D.K. Spady, J.A. Cuthbert, and M.N. Willard Overexpression of cholesterol 7alpha-hydroxylase (CYP7A) in mice lacking the low density lipoprotein (LDL) receptor gene. LDL transport and plasma LDL concentrations are reduced Biological Chemistry 273 1998 126 132 (Pubitemid 28042185)
18. M. Valgimigli, E. Merli, and P. Malagutti Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress Archives of Biochemistry and Biophysics 420 2003 255 261 (Pubitemid 37491109)
19. F.G. Wang, B. Liu, W. Wang, and R.B. Shi Study on adscription of drug constituents in Beagle dog plasma after intragastric administration with Jiangzhining extract China Journal of Chinese Materia Medica 33 2008 912 914
20. Z.J. Wang, Y.N. Ke, and ChengF W.L. Intervention study of atorvastatin on the platelet function of hyperlipemia rats Journal of China-Japan Friendship Hospital 21 2007 345 348
21. D.Y. Xu, B. Liu, W. Wang, and R.B. Shi Quantitative determination of 4 anthraquinone constituents in effective fractions of Jiangzhining by HPLC Journal of Beijing University of Traditional Chinese Medicine 33 2010 203 206
22. T.D. Yamamoto, and M.S. Brown The human LDL receptor: a cysteine-rich protein with multiple Alu Sequences in its mRNA Cell 39 1984 27 31
23. O. Yasunori, and A. Laura Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse The American Society for Clinical Investigation 95 1995 1124 1132
24. S. Yusuf, S. Reddy, and S. Ounpuu Global burden of cardiovascular diseases. I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization Circulation 104 2001 2746 2753 (Pubitemid 33108145)